Table 1.

Proportion of Patients Continuing TCZ and Treatment Duration According to Previous Biologic Treatment

Previous Biologics Received
0123 or more
ContinuedN (%)15 (83%)31 (66%)24 (51%)12 (60%)
Treatment Duration (Mths)*46272658
DiscontinuedN (%)3 (17%)16 (34%)23 (49%)8 (40%)
Treatment Duration (Mths)4.5142418
Lack of Efficacy/Toxicity2/17/99/143/5
  • *To date.